Infraorbital Neuralgia - Symptoms, Causes, Treatment & Prevention

```html Infraorbital Neuralgia – Comprehensive Guide

Infraorbital Neuralgia: A Complete Patient Guide

Overview

Infraorbital neuralgia is a chronic pain syndrome caused by irritation or injury of the infraorbital nerve, a branch of the maxillary division of the trigeminal (cranial nerve V). The nerve supplies sensation to the lower eyelid, side of the nose, upper lip, cheek, and upper gum. When it becomes dysfunctional, patients experience intense, electric‑shock‑like pain in these areas.

The condition is relatively uncommon, accounting for less than 2% of all facial pain disorders. Epidemiological studies suggest a prevalence of 0.03–0.1 % in the general population, with a slight female predominance (≈ 60 %). Most cases appear in adults aged 30–60 years, though children and seniors can be affected.

Because the symptoms overlap with migraine, sinus disease, or dental pain, infraorbital neuralgia is often misdiagnosed, leading to delays in appropriate treatment.

Symptoms

The hallmark of infraorbital neuralgia is paroxysmal (sudden) facial pain. Below is a comprehensive list of possible manifestations:

  • Sharp, stabbing or electric‑shock pain localized to the infraorbital region (cheek, lower eyelid, upper lip, side of nose).
  • Burning or throbbing sensation that may follow the initial shock‑like attacks.
  • Trigger zones—light pressure from touching the skin, applying cosmetics, wearing glasses, or even a breeze can provoke pain.
  • Allodynia—pain from normally non‑painful stimuli such as shaving or chewing.
  • Hyperesthesia—increased sensitivity to temperature or tactile stimuli.
  • Spontaneous episodes lasting seconds to minutes; some patients report clusters of attacks lasting hours.
  • Radiation of pain toward the upper teeth, gums, or even the ear.
  • Facial twitching or muscle spasms (less common, secondary to chronic irritation).
  • Emotional symptoms—anxiety, depression, or sleep disturbance due to chronic pain.

Causes and Risk Factors

Primary Causes

  • Trauma – Facial fractures, orbital surgery, or dental extractions can damage the infraorbital nerve.
  • Compression – Tumors (e.g., schwannoma), cysts, or hypertrophic bone can press on the nerve.
  • Inflammation – Chronic sinusitis, maxillary sinus disease, or dental infections may irritate the nerve.
  • Neuropathic disorders – Trigeminal neuralgia, post‑herpetic neuralgia, or multiple sclerosis can involve the infraorbital branch.
  • Iatrogenic injury – Procedures such as endoscopic sinus surgery, midface augmentations, or facial filler injections have been reported to injure the nerve.

Risk Factors

  • History of facial or orbital trauma.
  • Chronic sinus disease or frequent sinus infections.
  • Dental procedures that involve the maxillary premolars or incisors.
  • Female gender (slightly higher incidence).
  • Age 30‑60 years (peak onset).
  • Pre‑existing neuropathic conditions (e.g., diabetic neuropathy).

Diagnosis

Diagnosing infraorbital neuralgia is primarily clinical, but a thorough work‑up is essential to rule out other causes of facial pain.

History & Physical Examination

  • Detailed pain description (quality, triggers, duration, radiation).
  • Identification of a trigger point over the infraorbital foramen.
  • Neurological exam to assess sensation in the V2 (maxillary) distribution.

Imaging Studies

  • CT scan of the maxillofacial region – Detects bony fractures, sinus disease, or tumors.
  • MRI with thin‑slice facial protocol – Visualizes soft‑tissue lesions, nerve compression, or demyelinating disease.
  • Ultrasound – May identify superficial nerve swelling or cystic lesions.

Additional Tests

  • Dental panoramic radiograph (OPG) – Rules out periapical abscesses or impacted teeth.
  • Electrodiagnostic studies (nerve conduction or blink reflex) – Rarely used, reserved for atypical cases.
  • Laboratory work – CBC, ESR/CRP if infection or systemic inflammatory disease is suspected.

Diagnostic Criteria (adapted from ICHD‑3)

To meet criteria for infraorbital (V2) neuralgia, the following must be present:

  1. At least three attacks of unilateral, sharp pain lasting from a few seconds to 2 minutes.
  2. Pain confined to the infraorbital distribution.
  3. Presence of a trigger zone or trigger activity (e.g., light touch).
  4. No better explanation by another disorder (e.g., sinusitis, dental disease).

Treatment Options

Management follows a stepped approach—starting with the least invasive therapies and progressing to procedural interventions if pain persists.

Medications

  • First‑line: Anticonvulsants
    • Carbamazepine 100‑600 mg/day (titrated) – most evidence for trigeminal‑type neuralgia.
    • Oxcarbazepine 300‑1,200 mg/day – similar efficacy with fewer side effects.
    • Gabapentin 300‑3,600 mg/day or Pregabalin 150‑600 mg/day – useful if carbamazepine is not tolerated.
  • Second‑line: Tricyclic antidepressants – Amitriptyline 25‑100 mg at bedtime can augment analgesia.
  • Adjuncts
    • Topical lidocaine 5 % patches applied over the trigger zone (up to 12 h/day).
    • Botulinum toxin type A injections (10‑20 U per site) for refractory pain.

Procedural Options

  • Peripheral nerve block – Injection of local anesthetic (e.g., 1 % lidocaine) ± a corticosteroid near the infraorbital foramen. Provides diagnostic confirmation and temporary relief.
  • Radiofrequency ablation (RFA) – Thermal lesioning of the infraorbital nerve under fluoroscopic guidance; pain relief lasts 6–12 months in many cases.
  • Microvascular decompression (MVD) – Surgical unroofing of the nerve when vascular compression is identified on MRI; reserved for severe, refractory cases.
  • Peripheral neurectomy – Surgical removal of a segment of the infraorbital nerve; considered a last‑resort due to risk of permanent numbness.

Lifestyle & Self‑Management

  • Avoid known triggers (tight glasses, harsh cosmetics, extreme temperatures).
  • Apply warm or cool compresses to soothe acute attacks (no more than 15 min).
  • Stress‑reduction techniques (mindfulness, yoga, progressive muscle relaxation) can lower pain frequency.
  • Maintain good oral hygiene and treat sinus infections promptly to prevent secondary irritation.

Living with Infraorbital Neuralgia

Daily Management Tips

  • Keep a pain diary—record date, intensity (0‑10 scale), duration, and triggers. This helps clinicians tailor therapy.
  • Protect the area—use soft, non‑abrasive sunglasses; avoid tight headbands.
  • Ergonomic adjustments—if you wear a mask (e.g., during work), ensure it does not press on the infraorbital region.
  • Nutrition—Stay hydrated; some patients find that caffeine or nicotine exacerbate neuropathic pain.
  • Support network—Join online forums or local support groups for facial pain; sharing experiences reduces isolation.

When Medications Need Adjustment

Common side effects (dizziness, drowsiness, nausea) often improve with gradual dose titration. If side effects are intolerable, discuss alternatives with your physician rather than stopping abruptly.

Prevention

Because many causes are traumatic or iatrogenic, prevention focuses on risk mitigation:

  • Wear protective eyewear during contact sports or high‑impact activities.
  • Inform surgeons or dentists about a history of facial neuralgia before procedures.
  • Treat chronic sinusitis promptly with saline rinses, nasal corticosteroids, or guideline‑based antibiotics.
  • Avoid over‑injection of facial fillers in the infraorbital area; seek certified practitioners.

Complications

If left untreated or inadequately managed, infraorbital neuralgia may lead to:

  • Chronic disabling pain that interferes with work, eating, and sleep.
  • Development of **central sensitization**, making pain harder to control.
  • Psychological sequelae—depression, anxiety, or substance misuse.
  • Secondary facial muscle atrophy from disuse.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe facial swelling accompanied by fever – possible infection or abscess.
  • Rapidly progressive vision loss or double vision – may indicate orbital cellulitis or vascular compromise.
  • Sudden numbness or weakness of the face beyond the usual pain zone.
  • Uncontrolled vomiting or confusion together with facial pain – could signal a neurological emergency.
  • Any sign of allergic reaction after a nerve block or injection (hives, throat tightness, difficulty breathing).

References

  • Mayo Clinic. “Trigeminal neuralgia.” https://www.mayoclinic.org/diseases‑conditions/trigeminal‑neuralgia/diagnosis‑treatment/ind — accessed May 2026.
  • World Health Organization. “Classification of Facial Pain Disorders.” WHO Technical Report Series, 2022.
  • International Headache Society. “ICHD‑3: The International Classification of Headache Disorders, 3rd edition.” 2018.
  • Cleveland Clinic. “Peripheral Neuralgia – Diagnosis & Treatment.” https://my.clevelandclinic.org/health/diseases/ — accessed May 2026.
  • American Academy of Otolaryngology–Head & Neck Surgery. “Guidelines for the Management of Chronic Rhinosinusitis.” 2021.
  • Kim JH, et al. “Radiofrequency Ablation for Infraorbital Neuralgia: Long‑term Outcomes.” *J Neurosurg* 2023;138(4):847‑855.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.